Skip to Main Content

Paper Details

A new analytic tool for assessing the impact of the US Food and Drug Administration regulatory actions.
Pharmacoepidemiol Drug Saf
1
2023
Author NameAffiliation
Christine Y LuHarvard Medical School and the Harvard Pilgrim Health Care Institute
  • 1 - 1

Datasets

Release 1.2